Table 3.
Intervention (n=274) | Control (n=279) | Adjusted PR (95% CI)* | ||
---|---|---|---|---|
48 hours | ||||
Modern and appropriate methods | 9 (3%) | 3 (1%) | 1·83 (0·43–7·74) | |
Long-acting or permanent methods | 6 (2%) | 0 | 0† | |
Implant | 5 (2%) | 0 | 0† | |
Intrauterine device | 1 (<1%) | 0 | 0 | |
Female sterilisation | 0 | 0 | 0 | |
Vasectomy | 0 | 0 | 0 | |
Short-acting methods | 0 | 2 (1%) | 0 | |
Pill | 0 | 0 | 0 | |
Male condom | 0 | 2 (1%) | 0 | |
Female condom | 0 | 0 | 0 | |
Spermicide | 0 | 0 | 0 | |
Lactational amenorrhoea method | 3 (1%) | 1 (<1%) | 2·60 (0·20–33·60) | |
Non-modern or inappropriate methods | 1 (<1%) | 0 | 0 | |
Abstinence | 1 (<1%) | 0 | 0 | |
No method | 264 (96%) | 276 (99%) | 0·98 (0·77–1·24) | |
1 week | ||||
Modern and appropriate methods | 15 (5%) | 3 (1%) | 2·09 (0·78–10·75) | |
Long-acting or permanent methods | 12 (4%) | 0 | 0 | |
Implant | 11 (4%) | 0 | 0 | |
Intrauterine device | 1 (<1%) | 0 | 0 | |
Female sterilisation | 0 | 0 | 0 | |
Vasectomy | 0 | 0 | 0 | |
Short-acting methods | 0 | 2 (1%) | 0 | |
Pill | 0 | 0 | 0 | |
Male condom | 0 | 2 (1%) | 0 | |
Female condom | 0 | 0 | 0 | |
Spermicide | 0 | 0 | 0 | |
Lactational amenorrhoea method | 3 (1%) | 1 (<1%) | 2·51 (0·20–31·11) | |
Non-modern or inappropriate methods | 1 (<1%) | 1 (<1%) | 1·01 (0·06–16·14)‡ | |
Abstinence | 1 (<1%) | 1 (<1%) | 1·01 (0·06–16·14)‡ | |
No method | 258 (94%) | 274 (99%) | 0·96 (0·75–1·22) | |
6 weeks | ||||
Modern and appropriate methods | 32/272 (12%) | 16/276 (6%) | 6·79 (0·86–53·79) | |
Long-acting or permanent methods | 21/272 (8%) | 1/276 (<1%) | 72·37 (4·75–1103·82) | |
Implant | 20/272 (7%) | 1/276 (<1%) | 66·10 (4·33–1009·06) | |
Intrauterine device | 1/272 (<1%) | 0 | 0 | |
Female sterilisation | 0 | 0 | 0 | |
Vasectomy | 0 | 0 | 0 | |
Short-acting methods | 9/272 (3%) | 15/276 (5%) | 3·21 (0·02–651·22) | |
Injectable | 1/272 (<1%) | 0 | 0 | |
Pill | 0 | 0 | 0 | |
Male condom | 8/272 (3%) | 15/276 (5%) | 2·07 (0·00–4238·70) | |
Female condom | 0 | 0 | 0 | |
Emergency contraception | 0 | 0 | 0 | |
Spermicide | 0 | 0 | 0 | |
Lactational amenorrhoea method | 2/272 (<1%) | 0 | 0 | |
Non-modern or inappropriate methods | 3/272 (1%) | 19/276 (7%) | 0·10 (0·01–0·90) | |
Withdrawal | 1/272 (<1%) | 9/276 (3%) | 0·06 (0·00–0·91) | |
Abstinence | 2/272 (1%) | 8/276 (3%) | 0·23 (0·04–1·24) | |
Standard-day method | 0 | 1/276 (<1%) | 0 | |
Others | 0 | 1/276 (<1%) | 0 | |
No method | 237/272 (87%) | 241/276 (87%) | 1·17 (0·89–1·52) | |
6 months | ||||
Modern and appropriate methods | 82/269 (30%) | 58/275 (21%) | 1·58 (0·60–4·15) | |
Long-acting or permanent methods | 41/269 (15%) | 12/275 (4%) | 3·43 (1·39–8·48) | |
Implant | 40/269 (14%) | 10/275 (4%) | 4·06 (1·58–10·40) | |
Intrauterine device | 1/269 (<1%) | 2/275 (1%) | 0·92 (0·04–23·32) | |
Female sterilisation | 0 | 0 | 0 | |
Vasectomy | 0 | 0 | 0 | |
Short-acting methods | 40/269 (15%) | 46/275 (17%) | 1·04 (0·26–4·14) | |
Injectable | 13/269 (5%) | 5/275 (2%) | 5·24 (1·02–26·85) | |
Pill | 4/269 (1%) | 8/275 (3%) | 1·09 (0·20–5·89) | |
Male condom | 23/269 (9%) | 29/275 (11%) | 0·58 (0·07–4·83) | |
Female condom | 0 | 0 | 0 | |
Emergency contraception | 0 | 4/275 (1%) | 0 | |
Spermicide | 0 | 0 | 0 | |
Lactational amenorrhoea method | 1/269 (<1%) | 0 | 0 | |
Non-modern or inappropriate methods | 16/269 (6%) | 30/275 (11%) | 0·64 (0·11–3·78) | |
Withdrawal | 5/269 (2%) | 9/275 (3%) | 0·28 (0·08–1·01) | |
Abstinence | 2/269 (1%) | 1/275 (<1%) | 2·04 (0·19–22·42)† | |
Standard-day method | 9/269 (3%) | 15/275 (6%) | 0·65 (0·15–2·72) | |
Others | 0 | 5/275 (2%) | 0 | |
No method | 171/269 (64%) | 187/275 (68%) | 0·88 (0·43–1·79) |
Data are n (%) or n/N (%), unless otherwise indicated. PR=prevalence ratio.
Accounting for clustering effect and adjusted for living setting, education level, employment, and usual travel time to health centre.
2-sided p value Fisher's exact test >0·05.
Adjusting for clustering effect not possible.